|
|||||
|
|
Peripheral benzodiazepine receptors and glucose metabolism in human gliomas |
|
| Authors: | C. Ferrarese C. Pierpaoli I. Linfante R. H. Bobo B. Guthrie C. Kufta M. O. Duhaney J. Melisi M. J. Fulham |
| Affiliation: | (1) Neuroimaging Branch, The National Institute of Neurological Diseases and Stroke (NINDS), The National Institutes of Health (NIH), USA;(2) Surgical Neurology Branch, The National Institute of Neurological Diseases and Stroke (NINDS), The National Institutes of Health (NIH), USA;(3) Department of Neurosurgery, George Washington University Medical Center, Washington DC, USA;(4) Present address: Department of Neurology, University of Milan, Monza, Italy;(5) Present address: Medical Imaging Services, The PET Department, Royal Prince Alfred Hospital, Camperdown NSW, 2050 Sydney, Australia;(6) Room 1C451, Bldg. 10, The National Institutes of Health, 9000 Rockville Pike, 20892 Bethesda, MD, USA |
| Abstract: | Peripheral benzodiazepine receptors (PBR) are increased in gliomas and augmented glucose metabolism is seen in malignant brain tumors. We investigated the relationship between PBR density (Bmax) and glucose utilization rate (GUR) in 17 patients with cerebral gliomas of different grades. PBR Bmax was assessed by [3H]PK-11195in vitro binding in surgical specimens and GUR was measured by Positron Emission Tomography with [18F]2-Fluorodeoxyglucose before the surgery. In untreated tumors there was a positive correlation between PBR Bmax and GUR (2r = 0.84). This correlation was not observed in patients who had been treated with radiation and/or chemotherapy prior to surgery (r2 = 0.13). In addition, in untreated patients, the increase in PBR density and GUR appeared to be related to the degree of malignancy. |
| Keywords: | peripheral benzodiazepines receptor [3H]PK-11195 [18F]2-fluorodeoxyglucose PET glioma |
| 本文献已被 SpringerLink 等数据库收录！ | |